<li>5-htp<p>amitriptyline and 5-htp both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>abiraterone<p>abiraterone increases levels of amitriptyline by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Avoid coadministration of abiraterone with substrates of CYP2D6. If alternative therapy cannot be used, exercise caution and consider a dose reduction of the CYP2D6 substrate.</p></li><li>abobotulinumtoxina<p>abobotulinumtoxina and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>aclidinium<p>aclidinium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>albuterol<p>amitriptyline increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>alfentanil<p>alfentanil and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>almotriptan<p>almotriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>alprazolam<p>alprazolam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>altretamine<p>altretamine increases toxicity of amitriptyline by unknown mechanism. Use Caution/Monitor. Increased risk of orthostatic hypotension.</p></li><li>ambenonium<p>ambenonium increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>amiodarone<p>amiodarone will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>amisulpride<p>amisulpride and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>amobarbital<p>amobarbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>amobarbital will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>amobarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>amoxapine<p>amitriptyline and amoxapine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and amoxapine both increase  sedation. Use Caution/Monitor.</p></li><li>amphetamine<p>amphetamine increases effects of amitriptyline by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Combination may cause sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated.<span><br><br></span>amphetamine increases toxicity of amitriptyline by serotonin levels. Use Caution/Monitor. Closely monitor for signs and symptoms of serotonin syndrome (eg, agitation, tremor, tachycardia).</p></li><li>anticholinergic/sedative combos<p>anticholinergic/sedative combos and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>apomorphine<p>amitriptyline and apomorphine both increase  sedation. Use Caution/Monitor.</p></li><li>aprepitant<p>aprepitant will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>arformoterol<p>amitriptyline increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>aripiprazole<p>aripiprazole and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>armodafinil<p>armodafinil will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>amitriptyline increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>atazanavir<p>atazanavir will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>atazanavir increases levels of amitriptyline by unspecified interaction mechanism. Use Caution/Monitor.</p></li><li>atorvastatin<p>atorvastatin will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>atracurium<p>atracurium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>atropine<p>atropine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>atropine iv/im<p>atropine iv/im and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>azelastine<p>azelastine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>azithromycin<p>amitriptyline and azithromycin both increase  QTc interval. Use Caution/Monitor.</p></li><li>baclofen<p>baclofen and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>bambuterol<p>amitriptyline increases and bambuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>bedaquiline<p>amitriptyline and bedaquiline both increase  QTc interval. Modify Therapy/Monitor Closely. ECG should be monitored closely</p></li><li>belladonna alkaloids<p>belladonna alkaloids and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>belladonna and opium<p>belladonna and opium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>belladonna and opium and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>benperidol<p>benperidol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>benzphetamine<p>amitriptyline increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>benztropine<p>benztropine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely. Additive anticholinergic adverse effects may be seen with concurrent use. </p></li><li>bethanechol<p>bethanechol increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>brompheniramine<p>brompheniramine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>buclizine<p>buclizine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>buprenorphine<p>buprenorphine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>buprenorphine buccal<p>buprenorphine buccal and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>buprenorphine subdermal implant<p>amitriptyline, buprenorphine subdermal implant.
Either increases toxicity of the other by serotonin levels. Use Caution/Monitor. Concomitant use could result in life-threatening serotonin syndrome. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation, and during dose adjustment of the serotonergic drug. Discontinue buprenorphine if serotonin syndrome is suspected.</p></li><li>bupropion<p>amitriptyline increases toxicity of bupropion by unspecified interaction mechanism. Use Caution/Monitor. May lower seizure threshold; keep bupropion dose as low as possible.<span><br><br></span>bupropion will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>butabarbital<p>butabarbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>butabarbital will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>butabarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>butalbital<p>butalbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>butalbital will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>butalbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>butorphanol<p>butorphanol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>caffeine<p>amitriptyline increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>carbachol<p>carbachol increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>carbamazepine<p>carbamazepine will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>carbinoxamine<p>carbinoxamine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>carisoprodol<p>carisoprodol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>cevimeline<p>cevimeline increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>chloral hydrate<p>chloral hydrate and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>chlordiazepoxide<p>chlordiazepoxide and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>chlorpheniramine<p>chlorpheniramine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>chlorpromazine<p>chlorpromazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>chlorzoxazone<p>chlorzoxazone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>cimetidine<p>cimetidine will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>cinnarizine<p>cinnarizine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>cisatracurium<p>cisatracurium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>clarithromycin<p>clarithromycin will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>clemastine<p>clemastine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>clobazam<p>clobazam will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Lower doses of drugs metabolized by CYP2D6 may be required when used concomitantly. <span><br><br></span>amitriptyline, clobazam. Other (see comment). Use Caution/Monitor. 
Comment: Concomitant administration can increase the potential for CNS effects (e.g., increased sedation or respiratory depression).</p></li><li>clomethiazole<p>amitriptyline and clomethiazole both increase  sedation. Use Caution/Monitor.</p></li><li>clomipramine<p>amitriptyline and clomipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and clomipramine both increase  sedation. Use Caution/Monitor.</p></li><li>clonazepam<p>clonazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>clorazepate<p>clorazepate and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>clotrimazole<p>clotrimazole will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>clozapine<p>clozapine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>cobicistat<p>cobicistat will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Carefully titrate antidepressant to the desired effect, including using the lowest feasible initial or maintenance dose, and monitoring for antidepressant response</p></li><li>cocaine<p>amitriptyline and cocaine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>codeine<p>codeine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>conivaptan<p>conivaptan will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>crizotinib<p>crizotinib and amitriptyline both increase  QTc interval. Use Caution/Monitor. ECG monitoring is recommended, along with drugs that may prolong the QT interval.</p></li><li>cyclizine<p>cyclizine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>cyclizine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>cyclobenzaprine<p>cyclobenzaprine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>cyclosporine<p>cyclosporine will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>cyclosporine will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>cyproheptadine<p>cyproheptadine and amitriptyline both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline increases and cyproheptadine decreases serotonin levels. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>daclatasvir<p>daclatasvir will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>dantrolene<p>dantrolene and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>darifenacin<p>darifenacin will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>darifenacin and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>darunavir<p>darunavir will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>dasatinib<p>amitriptyline and dasatinib both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>debrisoquine<p>amitriptyline decreases effects of debrisoquine by Other (see comment). Use Caution/Monitor. 
Comment: Inhibition of uptake by adrenergic neurons.</p></li><li>delavirdine<p>delavirdine will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.</p></li><li>desflurane<p>desflurane and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>desipramine<p>amitriptyline and desipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and desipramine both increase  sedation. Use Caution/Monitor.</p></li><li>dexchlorpheniramine<p>dexchlorpheniramine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>dexfenfluramine<p>amitriptyline increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline and dexfenfluramine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>dexmedetomidine<p>dexmedetomidine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>dexmethylphenidate<p>amitriptyline increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dextroamphetamine<p>amitriptyline increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline and dextroamphetamine both increase  serotonin levels. Modify Therapy/Monitor Closely.<span><br><br></span>amitriptyline increases effects of dextroamphetamine by unknown mechanism. Use Caution/Monitor.</p></li><li>dextromoramide<p>dextromoramide and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>diamorphine<p>diamorphine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>diazepam<p>diazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>dicyclomine<p>dicyclomine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>diethylpropion<p>amitriptyline increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>difenoxin hcl<p>difenoxin hcl and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>dihydroergotamine<p>amitriptyline and dihydroergotamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>dihydroergotamine intranasal<p>amitriptyline and dihydroergotamine intranasal both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>diltiazem<p>diltiazem will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>diltiazem will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>dimenhydrinate<p>dimenhydrinate and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>diphenhydramine<p>diphenhydramine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.<span><br><br></span>diphenhydramine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>diphenoxylate hcl<p>diphenoxylate hcl and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>dipipanone<p>dipipanone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>distigmine<p>distigmine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dobutamine<p>amitriptyline increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dolasetron<p>amitriptyline and dolasetron both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>donepezil<p>donepezil increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>dopamine<p>amitriptyline increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dopexamine<p>amitriptyline increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>dosulepin<p>amitriptyline and dosulepin both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and dosulepin both increase  sedation. Use Caution/Monitor.</p></li><li>doxepin<p>amitriptyline and doxepin both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and doxepin both increase  sedation. Use Caution/Monitor.</p></li><li>doxylamine<p>doxylamine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>droperidol<p>droperidol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>echothiophate iodide<p>echothiophate iodide increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>edrophonium<p>edrophonium increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>efavirenz<p>efavirenz will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>efavirenz will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>eletriptan<p>eletriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>eliglustat<p>eliglustat increases levels of amitriptyline by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Monitor therapeutic drug concentrations, as indicated, or consider reducing the dosage of the concomitant drug and titrate to clinical effect.<span><br><br></span>eliglustat increases levels of amitriptyline by P-glycoprotein (MDR1) efflux transporter. Modify Therapy/Monitor Closely. Monitor therapeutic drug concentrations, as indicated, or consider reducing the dosage of the P-gp substrate and titrate to clinical effect.</p></li><li>elvitegravir/cobicistat/emtricitabine/tenofovir df<p>elvitegravir/cobicistat/emtricitabine/tenofovir df increases levels of amitriptyline by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Cobicistat is a CYP2D6 inhibitor; caution with CYP2D6 substrates for which elevated plasma concentrations are associated with serious and/or life-threatening events.</p></li><li>enflurane<p>enflurane and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>ephedrine<p>amitriptyline increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline increases effects of ephedrine by unknown mechanism. Use Caution/Monitor.</p></li><li>ephedrine (pulmonary)<p>amitriptyline increases and ephedrine (pulmonary) decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .<span><br><br></span>amitriptyline increases effects of ephedrine (pulmonary) by unknown mechanism. Use Caution/Monitor.</p></li><li>epinephrine<p>amitriptyline increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline increases effects of epinephrine by unknown mechanism. Use Caution/Monitor.</p></li><li>epinephrine racemic<p>amitriptyline increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline increases effects of epinephrine racemic by unknown mechanism. Use Caution/Monitor.</p></li><li>ergotamine<p>amitriptyline and ergotamine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>esomeprazole<p>esomeprazole will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.</p></li><li>estazolam<p>estazolam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>ethanol<p>amitriptyline and ethanol both increase  sedation. Use Caution/Monitor.</p></li><li>ethotoin<p>ethotoin will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>ethotoin will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>etomidate<p>etomidate and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>etravirine<p>etravirine will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.</p></li><li>ezogabine<p>ezogabine, amitriptyline.
Either increases toxicity of the other by QTc interval. Use Caution/Monitor. Slight and transient QT-prolongation observed with ezogabine, particularly when dose titrated to 1200 mg/day. QT interval should be monitored when ezogabine is prescribed with agents known to increase QT interval.</p></li><li>felbamate<p>felbamate will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.</p></li><li>felodipine<p>felodipine will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>fenfluramine<p>amitriptyline increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline and fenfluramine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>fesoterodine<p>fesoterodine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>flavoxate<p>flavoxate and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>flecainide<p>amitriptyline and flecainide both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>fluconazole<p>fluconazole will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>fluconazole will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>fluoxetine<p>amitriptyline and fluoxetine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>fluphenazine<p>fluphenazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>flurazepam<p>flurazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>fluvoxamine<p>fluvoxamine will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>amitriptyline and fluvoxamine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>formoterol<p>amitriptyline increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>fosamprenavir<p>fosamprenavir will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>foscarnet<p>amitriptyline and foscarnet both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>fosphenytoin<p>fosphenytoin will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>fosphenytoin will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>fospropofol<p>fospropofol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>frovatriptan<p>frovatriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>galantamine<p>galantamine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>glycopyrrolate<p>glycopyrrolate and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.<span><br><br></span>amitriptyline increases levels of glycopyrrolate by unknown mechanism. Use Caution/Monitor.</p></li><li>glycopyrrolate inhaled<p>glycopyrrolate inhaled and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.<span><br><br></span>amitriptyline increases levels of glycopyrrolate inhaled by unknown mechanism. Use Caution/Monitor.</p></li><li>grapefruit<p>grapefruit will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>haloperidol<p>haloperidol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>henbane<p>henbane and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hexobarbital<p>hexobarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>homatropine<p>homatropine and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>huperzine a<p>huperzine a increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>hydrocodone<p>hydrocodone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>hydromorphone<p>hydromorphone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>hydroxyzine<p>hydroxyzine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>hyoscyamine<p>hyoscyamine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>hyoscyamine spray<p>hyoscyamine spray and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>iloperidone<p>amitriptyline and iloperidone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>iloperidone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>imipramine<p>amitriptyline and imipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and imipramine both increase  sedation. Use Caution/Monitor.</p></li><li>incobotulinumtoxina<p>incobotulinumtoxina and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>indacaterol, inhaled<p>indacaterol, inhaled, amitriptyline. QTc interval. Use Caution/Monitor. Indacaterol should be administered with extreme caution to patients treated with TCAs. Drugs that are known to prolong the QTc interval may have an increased the risk of ventricular arrhythmias.</p></li><li>indinavir<p>indinavir will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>ipratropium<p>ipratropium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor. Due to the poor systemic absorption of ipratropium,  interaction unlikely at regularly recommended dosages.</p></li><li>isoniazid<p>isoniazid will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>amitriptyline and isoniazid both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>isoproterenol<p>amitriptyline increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>itraconazole<p>itraconazole will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>ketamine<p>ketamine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>ketoconazole<p>ketoconazole will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>ketoconazole will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>ketotifen, ophthalmic<p>amitriptyline and ketotifen, ophthalmic both increase  sedation. Use Caution/Monitor.</p></li><li>l-tryptophan<p>amitriptyline and l-tryptophan both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>lapatinib<p>amitriptyline and lapatinib both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>levalbuterol<p>amitriptyline increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>levofloxacin<p>amitriptyline and levofloxacin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>levorphanol<p>levorphanol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>lisdexamfetamine<p>amitriptyline increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>lithium<p>amitriptyline and lithium both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>lofepramine<p>amitriptyline and lofepramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and lofepramine both increase  sedation. Use Caution/Monitor.</p></li><li>lofexidine<p>amitriptyline and lofexidine both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline decreases effects of lofexidine by unspecified interaction mechanism. Use Caution/Monitor.</p></li><li>loprazolam<p>loprazolam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>loratadine<p>loratadine will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>lorazepam<p>lorazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>lorcaserin<p>lorcaserin will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>lormetazepam<p>lormetazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>loxapine<p>loxapine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>loxapine inhaled<p>loxapine inhaled and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>lsd<p>amitriptyline and lsd both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>lurasidone<p>lurasidone increases effects of amitriptyline by Other (see comment). Use Caution/Monitor. 
Comment: Potential  for increased risk of hypotension with concurrent use. Monitor blood pressure and adjust  dose of  antihypertensive agent as needed.<span><br><br></span>lurasidone, amitriptyline.
Either increases toxicity of the other by sedation. Use Caution/Monitor. Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.</p></li><li>maprotiline<p>amitriptyline and maprotiline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and maprotiline both increase  sedation. Use Caution/Monitor.</p></li><li>maraviroc<p>maraviroc, amitriptyline.
Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Increased risk of orthostatic hypotension.</p></li><li>marijuana<p>amitriptyline and marijuana both increase  sedation. Use Caution/Monitor.</p></li><li>meclizine<p>meclizine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>melatonin<p>amitriptyline and melatonin both increase  sedation. Use Caution/Monitor.</p></li><li>mepenzolate<p>mepenzolate and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>meperidine<p>meperidine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>mephobarbital<p>mephobarbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>mephobarbital will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>mephobarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>meprobamate<p>amitriptyline and meprobamate both increase  sedation. Use Caution/Monitor.</p></li><li>metaproterenol<p>amitriptyline increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>metaxalone<p>metaxalone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>methadone<p>amitriptyline and methadone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>methadone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>methamphetamine<p>amitriptyline increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>methocarbamol<p>methocarbamol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>methscopolamine<p>methscopolamine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>methylenedioxymethamphetamine<p>amitriptyline increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>methylphenidate<p>amitriptyline increases and methylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>mianserin<p>amitriptyline and mianserin both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and mianserin both increase  sedation. Use Caution/Monitor.</p></li><li>midazolam<p>midazolam will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>midazolam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>midodrine<p>amitriptyline increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>mifepristone<p>mifepristone, amitriptyline. QTc interval. Modify Therapy/Monitor Closely. Use alternatives if available.</p></li><li>mipomersen<p>mipomersen, amitriptyline.
Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. 
Comment: Both drugs have potential to increase hepatic enzymes; monitor LFTs.</p></li><li>mirabegron<p>mirabegron will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.</p></li><li>mirtazapine<p>amitriptyline and mirtazapine both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline and mirtazapine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>modafinil<p>modafinil will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>amitriptyline increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>morphine<p>morphine and amitriptyline both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline and morphine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>motherwort<p>amitriptyline and motherwort both increase  sedation. Use Caution/Monitor.</p></li><li>moxonidine<p>amitriptyline and moxonidine both increase  sedation. Use Caution/Monitor.</p></li><li>nabilone<p>amitriptyline and nabilone both increase  sedation. Use Caution/Monitor.</p></li><li>nalbuphine<p>nalbuphine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>naratriptan<p>naratriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>nefazodone<p>nefazodone will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>nefazodone will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>nefopam<p>nefopam, amitriptyline. Mechanism: unspecified interaction mechanism. Use Caution/Monitor. Use combination with caution.</p></li><li>nelfinavir<p>nelfinavir will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>neostigmine<p>neostigmine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>nicardipine<p>nicardipine will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>nifedipine<p>nifedipine will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>norepinephrine<p>amitriptyline increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.<span><br><br></span>amitriptyline increases effects of norepinephrine by unknown mechanism. Use Caution/Monitor.</p></li><li>nortriptyline<p>amitriptyline and nortriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and nortriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>ofloxacin<p>amitriptyline and ofloxacin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>olanzapine<p>olanzapine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>olodaterol inhaled<p>amitriptyline and olodaterol inhaled both increase  QTc interval. Use Caution/Monitor. TCAs prolong the QTc interval and may potentiate the effects of beta2 agonists on the cardiovascular system; increased risk of ventricular arrhythmias</p></li><li>ombitasvir/paritaprevir/ritonavir<p>ombitasvir/paritaprevir/ritonavir will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. Paritaprevir and ritonavir inhibit P-gp. Caution if coadministered with P-gp substrates.</p></li><li>onabotulinumtoxina<p>onabotulinumtoxina and amitriptyline both decrease  cholinergic effects/transmission. Modify Therapy/Monitor Closely.</p></li><li>opium tincture<p>opium tincture and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>orphenadrine<p>amitriptyline and orphenadrine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>orphenadrine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>osimertinib<p>osimertinib and amitriptyline both increase  QTc interval. Use Caution/Monitor. Conduct periodic monitoring with ECGs and electrolytes in patients taking drugs known to prolong the QTc interval.</p></li><li>oxazepam<p>oxazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>oxybutynin<p>oxybutynin and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxybutynin topical<p>oxybutynin topical and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxybutynin transdermal<p>oxybutynin transdermal and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>oxycodone<p>oxycodone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>oxymetazoline intranasal<p>amitriptyline increases effects of oxymetazoline intranasal by pharmacodynamic synergism. Use Caution/Monitor. TCAs inhibit norepinephrine uptake in adrenergic neurons, thereby increasing synaptic norepinephrine levels. Coadministration with alpha1 agonists may cause increased adrenergic receptor stimulation. When oxymetazoline is combined with intranasal tetracaine for dental anesthesia, avoid or use alternant anesthetic in patients taking TCAs.</p></li><li>oxymorphone<p>oxymorphone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>paliperidone<p>amitriptyline and paliperidone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>paliperidone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>pancuronium<p>pancuronium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>papaveretum<p>papaveretum and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>papaverine<p>amitriptyline and papaverine both increase  sedation. Use Caution/Monitor.</p></li><li>paroxetine<p>amitriptyline and paroxetine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>pasireotide<p>amitriptyline and pasireotide both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>pazopanib<p>amitriptyline and pazopanib both increase  QTc interval. Use Caution/Monitor.</p></li><li>peginterferon alfa 2b<p>peginterferon alfa 2b, amitriptyline. Other (see comment). Use Caution/Monitor. 
Comment: When patients are administered peginterferon alpha-2b with CYP2D6 substrates, the therapeutic effect of these drugs may be altered. Peginterferon alpha-2b may increase or decrease levels of CYP2D6 substrate.</p></li><li>pentazocine<p>pentazocine and amitriptyline both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline and pentazocine both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>pentobarbital<p>pentobarbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>pentobarbital will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>pentobarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>perphenazine<p>perphenazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>phendimetrazine<p>amitriptyline increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenobarbital<p>phenobarbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>phenobarbital will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>phenobarbital will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>phenobarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>phentermine<p>amitriptyline increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenylephrine<p>amitriptyline increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>phenylephrine ophthalmic<p>amitriptyline, phenylephrine ophthalmic. Other (see comment). Use Caution/Monitor. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>phenylephrine po<p>amitriptyline increases and phenylephrine po decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.  .</p></li><li>phenytoin<p>phenytoin will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Monitor therapeutic efficacy of amitriptyline; an increased dose may be required. Serum phenytoin levels should be obtained when tricyclic antidepressant agents are added to therapy due to the potential for impaired phenytoin metabolism and decreased seizure threshold.  Tricyclic antidepressants when given concomitantly with anticonvulsants can increase CNS depression.<span><br><br></span>phenytoin will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. Monitor therapeutic efficacy of amitriptyline; an increased dose may be required. Serum phenytoin levels should be obtained when tricyclic antidepressant agents are added to therapy due to the potential for impaired phenytoin metabolism and decreased seizure threshold.  Tricyclic antidepressants when given concomitantly with anticonvulsants can increase CNS depression.</p></li><li>pholcodine<p>amitriptyline and pholcodine both increase  sedation. Use Caution/Monitor.</p></li><li>physostigmine<p>physostigmine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>pilocarpine<p>pilocarpine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>pilocarpine ophthalmic<p>pilocarpine ophthalmic increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>pimozide<p>pimozide and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>pirbuterol<p>amitriptyline increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ponatinib<p>ponatinib increases levels of amitriptyline by P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>posaconazole<p>amitriptyline and posaconazole both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>pralidoxime<p>pralidoxime and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>primidone<p>primidone will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>primidone will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>primidone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>prochlorperazine<p>prochlorperazine and amitriptyline both increase  QTc interval. Use Caution/Monitor.<span><br><br></span>prochlorperazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>promethazine<p>promethazine and amitriptyline both increase  QTc interval. Use Caution/Monitor.<span><br><br></span>promethazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>propantheline<p>propantheline and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>propofol<p>propofol and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>propylhexedrine<p>amitriptyline increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>protriptyline<p>amitriptyline and protriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and protriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>pseudoephedrine<p>amitriptyline increases and pseudoephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>pyridostigmine<p>pyridostigmine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>quazepam<p>quazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>quercetin<p>quercetin will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>quetiapine<p>quetiapine and amitriptyline both increase  sedation. Use Caution/Monitor.<span><br><br></span>quetiapine, amitriptyline.
Either increases toxicity of the other by QTc interval. Use Caution/Monitor. Avoid use with drugs that prolong QT and in patients with risk factors for prolonged QT interval. Postmarketing cases show QT prolongation with overdose in patients with concomitant illness or with drugs known to cause electrolyte imbalance or prolong QT.</p></li><li>quinine<p>amitriptyline and quinine both increase  QTc interval. Use Caution/Monitor.</p></li><li>ramelteon<p>amitriptyline and ramelteon both increase  sedation. Use Caution/Monitor.</p></li><li>ranolazine<p>amitriptyline and ranolazine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>rapacuronium<p>rapacuronium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>reserpine<p>reserpine will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>rifabutin<p>rifabutin will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>rifabutin decreases levels of amitriptyline by increasing metabolism. Use Caution/Monitor.</p></li><li>rifampin<p>rifampin will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>rifampin will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>rifampin will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>rifapentine<p>rifapentine will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.</p></li><li>rilpivirine<p>rilpivirine increases toxicity of amitriptyline by QTc interval. Use Caution/Monitor. Rilpivirine should be used with caution when co-administered with a drug with a known risk of Torsades de Pointes.</p></li><li>rimabotulinumtoxinb<p>rimabotulinumtoxinb and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>risperidone<p>amitriptyline and risperidone both increase  QTc interval. Modify Therapy/Monitor Closely.<span><br><br></span>risperidone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>ritonavir<p>ritonavir will increase the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.<span><br><br></span>ritonavir will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>rivastigmine<p>rivastigmine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>rizatriptan<p>rizatriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>rocuronium<p>rocuronium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>romidepsin<p>amitriptyline and romidepsin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>salmeterol<p>amitriptyline increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>same<p>amitriptyline and same both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>scopolamine<p>scopolamine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>scullcap<p>amitriptyline and scullcap both increase  sedation. Use Caution/Monitor.</p></li><li>secobarbital<p>secobarbital will decrease the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>secobarbital and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>sertindole<p>sertindole and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>sevoflurane<p>sevoflurane and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>shepherd's purse<p>amitriptyline and shepherd's purse both increase  sedation. Use Caution/Monitor.</p></li><li>simvastatin<p>simvastatin will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>sirolimus<p>sirolimus will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>sodium sulfate/potassium sulfate/magnesium sulfate<p>amitriptyline, sodium sulfate/potassium sulfate/magnesium sulfate. Other (see comment). Use Caution/Monitor. 
Comment: Caution when bowel preps are used with drugs that cause SIADH or NSAIDs; increased risk for water retention or electrolyte imbalance.</p></li><li>sodium sulfate/potassium sulfate/magnesium sulfate/polyethylene glycol<p>amitriptyline, sodium sulfate/potassium sulfate/magnesium sulfate/polyethylene glycol. Other (see comment). Use Caution/Monitor. 
Comment: Caution when bowel preps are used with drugs that cause SIADH or NSAIDs; increased risk for water retention or electrolyte imbalance.</p></li><li>solifenacin<p>solifenacin and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>sorafenib<p>sorafenib and amitriptyline both increase  QTc interval. Use Caution/Monitor.</p></li><li>spironolactone<p>spironolactone will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>st john's wort<p>st john's wort will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely.<span><br><br></span>st john's wort will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>succinylcholine<p>succinylcholine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>sufentanil<p>sufentanil and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>sulfamethoxazole<p>amitriptyline and sulfamethoxazole both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>sulpiride<p>sulpiride and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>sumatriptan<p>sumatriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>sumatriptan intranasal<p>sumatriptan intranasal and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>sumatriptan transdermal<p>sumatriptan transdermal and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>suvorexant<p>suvorexant and amitriptyline both increase  sedation. Modify Therapy/Monitor Closely. Dosage adjustments of suvorexant and concomitant CNS depressants may be necessary</p></li><li>tacrine<p>tacrine increases and amitriptyline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Modify Therapy/Monitor Closely.</p></li><li>tacrolimus<p>tacrolimus will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>tapentadol<p>tapentadol and amitriptyline both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline and tapentadol both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>telavancin<p>amitriptyline and telavancin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>telithromycin<p>amitriptyline and telithromycin both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>temazepam<p>temazepam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>terbutaline<p>amitriptyline increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>terfenadine<p>terfenadine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>teriflunomide<p>teriflunomide decreases levels of amitriptyline by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.</p></li><li>thioridazine<p>thioridazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>thiothixene<p>thiothixene and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>tiotropium<p>tiotropium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tolterodine<p>tolterodine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tolvaptan<p>tolvaptan will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.</p></li><li>topiramate<p>amitriptyline and topiramate both increase  sedation. Modify Therapy/Monitor Closely.</p></li><li>tramadol<p>tramadol and amitriptyline both increase  sedation. Use Caution/Monitor.<span><br><br></span>amitriptyline and tramadol both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>trazodone<p>trazodone will decrease the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor.<span><br><br></span>amitriptyline and trazodone both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and trazodone both increase  sedation. Use Caution/Monitor.</p></li><li>triazolam<p>triazolam and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>triclofos<p>triclofos and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>trifluoperazine<p>trifluoperazine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>trihexyphenidyl<p>trihexyphenidyl and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor. Potential for additive anticholinergic effects.</p></li><li>trimethoprim<p>amitriptyline and trimethoprim both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>trimipramine<p>amitriptyline and trimipramine both decrease  cholinergic effects/transmission. Use Caution/Monitor.<span><br><br></span>amitriptyline and trimipramine both increase  sedation. Use Caution/Monitor.</p></li><li>tropisetron<p>amitriptyline and tropisetron both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>trospium chloride<p>trospium chloride and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>tubocurarine<p>tubocurarine and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>valerian<p>valerian and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>vecuronium<p>vecuronium and amitriptyline both decrease  cholinergic effects/transmission. Use Caution/Monitor.</p></li><li>venlafaxine<p>amitriptyline and venlafaxine both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>verapamil<p>verapamil will increase the level or effect of amitriptyline by  P-glycoprotein (MDR1) efflux transporter. Use Caution/Monitor. The frequency and severity of amitriptyline adverse effects (sedation, anticholinergic effects and orthostatic hypotension) may be increased. Cardiac dysrhythmic effects may be additive. </p></li><li>voriconazole<p>voriconazole will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Monitor.<span><br><br></span>amitriptyline and voriconazole both increase  QTc interval. Modify Therapy/Monitor Closely.</p></li><li>xylometazoline<p>amitriptyline increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>yohimbine<p>amitriptyline increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.</p></li><li>ziconotide<p>amitriptyline and ziconotide both increase  sedation. Use Caution/Monitor.</p></li><li>ziprasidone<p>ziprasidone and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li><li>zolmitriptan<p>zolmitriptan and amitriptyline both increase  serotonin levels. Modify Therapy/Monitor Closely.</p></li><li>zotepine<p>zotepine and amitriptyline both increase  sedation. Use Caution/Monitor.</p></li>